Personalized Living Plan to Improve Metabolic Health in Adults with Metabolic Syndrome
Official title: Effectiveness of the Personalized Responses & Integrated Systems for Metabolism (PRISM) on Improving Insulin Resistance Among Adults With Metabolic Syndrome: A Pilot Study (PRISM-I)
Run by National University Health System, Singapore · NCT07710274 · Data updated 2026-11-12
This pilot study tests a personalized lifestyle plan—time-restricted eating, more activity, a low-glycemic diet, and better sleep—to see if it can improve insulin resistance in adults with metabolic syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 70 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | National University Health System, Singapore Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | September 17, 2026 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT07710274 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21-70 with metabolic syndrome and insulin resistance (HOMA-IR ≥ 2.5), willing to use CGM, a smart ring, and a food-logging app, and able to consent in English.
✕Probably not a fit
Individuals with insulin therapy, pregnancy, or inability to engage with digital monitoring may not experience benefit from this pilot.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The PRISM-I pilot study aims to determine whether a precision lifestyle program is feasible for adults with metabolic syndrome and insulin resistance. It will evaluate recruitment, retention, adherence, and the usability of a digital platform used to deliver four lifestyle interventions: time-restricted eating, increased physical activity, a low-glycemic load diet, and sleep hygiene. The study will also explore preliminary effects on insulin resistance (HOMA-IR) and a range of biochemical, anthropometric, behavioral, cognitive, and psychological outcomes to inform a larger definitive trial. Findings will help identify behavioral and physiological pathways through which these interventions might improve insulin resistance.
Why it matters
Potential benefit: If successful, participants may experience improvements in insulin sensitivity and related metabolic markers through a personalized, lifestyle-based approach.
How similar studies have gone: Previous work in precision lifestyle approaches for metabolic health has shown feasibility and signals of benefit, though this study is a pilot designed to inform a larger trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants will be included for if they are: * (1) adults aged 21-70 years old; * (2) willing and able to comply with using a CGM, smart ring, food logging app * (3) able to provide written informed consent; * (4) English-speaking and literate; * (5) meet the inclusion criteria for metabolic syndrome and insulin resistance. * The criteria for insulin resistance is HOMA-IR ≥ 2.5. * The criteria for metabolic syndrome is to have high waist circumference (≥ 80cm for females and ≥ 90cm for males); and any two of the four below: * (1) raised triglycerides: 1.7 mmol/L or on treatment; * (2) reduced HDL cholesterol: \< 1.0 mmol/L (40 mg/dL) in men, \< 1.3 mmol/L (50 mg/dL) in women, or on treatment; * (3) high blood pressure: 130/85 mmHg or on treatment; or * (4) raised fasting glucose: 5.6 mmol/L (100 mg/dL) or previously diagnosed with T2DM Exclusion Criteria: Participants will be excluded from both phases if they are: * (1) on insulin therapy; * (2) are pregnant or lactating; * (3) have a medical condition or are on a treatment that may interfere with study participation or metabolic assessments, as determined by the study investigators; * (4) currently participating in other lifestyle modification programs.
Where it's running
-
National University of Singapore
Singapore, Singapore Recruiting
Study contacts
- Study coordinator: Jocelyn Chew
- Email: dbi-lab@nus.edu.sg
- Phone: +6565168687
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effect of a Resistance Exercise Program on IGF-1 Levels in Knee Osteoarthritis
A structured 8-week resistance exercise program is being tested to see if it changes blood IGF-1 levels and improves knee OA symptoms in adults with knee OA and metabolic traits.
-
Preoperative Carbohydrate Drink Before Bariatric Surgery in Metabolic Syndrome
This trial tests whether drinking a carbohydrate beverage before bariatric surgery helps speed up recovery of digestion in adults with metabolic syndrome.
-
Duodenal-jejunal bypass sleeve for obesity and metabolic syndrome
This study tests whether placing a duodenal-jejunal bypass sleeve helps people with obesity improve health outcomes.
-
How higher blood lactate affects fat and carbohydrate metabolism
This test raises blood lactate with an IV in adults with and without metabolic syndrome to see if higher lactate lowers fat breakdown and worsens glucose tolerance.
-
Community health coach plus AI app program to help people with metabolic syndrome manage diet and heart risk
This program will test whether a community health coach working with an AI-powered app can help adults with metabolic syndrome improve their eating habits, self-control, and cardiovascular risk.
-
Pulsendo for Type 2 Diabetes and fatty liver disease in adults
This study tests the pulsENDO procedure in adults with type 2 diabetes who still have high blood sugar despite meds, to see if it helps their diabetes and fatty liver disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.